Shopping Cart 0
Cart Subtotal
USD 0

Horizon Discovery Group Plc (HZD) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Horizon Discovery Group Plc (Horizon Discovery) is a life science company that discovers and develops genetically-modified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers services such as CRISPR screening, combination screening, in vivo assay services and cell-based assays, among others. Horizon Discovery offers its products and services to genomic research organizations, pharmaceutical, biotechnology and diagnostic companies and academic research centers for the formulation of customized medicines. The company has operations in the UK and the US. Horizon Discovery is headquartered in Cambridge, the UK.

Horizon Discovery Group Plc (HZD)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Horizon Discovery Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Horizon Discovery Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Horizon Discovery Group Plc, Medical Equipment, Deal Details 11

Asset Purchase 11

Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 11

Private Equity 12

ValueAct Capital Acquires Additional Stake in Horizon Discovery Group from Woodford Investment Management 12

Partnerships 13

Horizon Discovery Enters into Licensing Agreement for Transposon Based Technology Platform 13

Horizon Discovery Enters into Licensing and Supply Agreement with Adarza BioSystems 14

Horizon Discovery Enters into Licensing Agreement with Japanese Medical University 15

Horizon Discovery Enters Into Licensing Agreement With ATCC 16

Horizon Diagnostics Enters Into Licensing Agreement With UK NEQAS 17

Horizon Discovery Enters into Partnership 18

Sophia Genetics Enters into Agreement with Horizon Discovery Group 19

Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems 20

Agena Bioscience Enters into Agreement with Horizon Discovery 21

CareDx Enters into Co-Development Agreement with Horizon Discovery 22

Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 23

Horizon Diagnostics Enters Into Distribution Agreement With Riken Genesis 24

Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 25

Horizon Diagnostics Enters Into Distribution Agreement With Diatech Pharmacogenetics For Molecular Reference Standards 26

Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 27

Horizon Discovery Enters into Licensing Agreement with US Immuno-Oncology Company 28

Equity Offering 29

Horizon Discovery Raises USD104.6 million in Private Placement of Shares 29

Horizon Discovery Group Plc-Key Competitors 30

Horizon Discovery Group Plc-Key Employees 31

Horizon Discovery Group Plc-Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Joint Venture 33

Recent Developments 34

Product News 34

Sep 25, 2017: Horizon Discovery introduces OncoSpan, the world's largest DNA multiplex Reference Standard for oncology 34

Feb 20, 2017: Horizon Discovery Launches Multiplex I cfDNA Reference Standard Set in Synthetic Plasma 35

Other Significant Developments 36

Mar 14, 2017: Horizon Discovery Enters into Agreement with a Leading Global Molecular Diagnostics Provider for Reference Standards for Non-Invasive Prenatal Testing 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Horizon Discovery Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Horizon Discovery Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Horizon Discovery Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Horizon Discovery Group Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Horizon Discovery Group Plc, Medical Equipment, Key Facts, 2017 2

Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Horizon Discovery Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Horizon Discovery Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Horizon Discovery Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Horizon Discovery Group Plc, Deals By Market, 2012 to YTD 2018 8

Horizon Discovery Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Horizon Discovery Completes Acquisition of Combination High Throughput Screening from Zalicus 11

ValueAct Capital Acquires Additional Stake in Horizon Discovery Group from Woodford Investment Management 12

Horizon Discovery Enters into Licensing Agreement for Transposon Based Technology Platform 13

Horizon Discovery Enters into Licensing and Supply Agreement with Adarza BioSystems 14

Horizon Discovery Enters into Licensing Agreement with Japanese Medical University 15

Horizon Discovery Enters Into Licensing Agreement With ATCC 16

Horizon Diagnostics Enters Into Licensing Agreement With UK NEQAS 17

Horizon Discovery Enters into Partnership 18

Sophia Genetics Enters into Agreement with Horizon Discovery Group 19

Horizon Discovery Group Enters into Co-Development Agreement with Ventana Medical Systems 20

Agena Bioscience Enters into Agreement with Horizon Discovery 21

CareDx Enters into Co-Development Agreement with Horizon Discovery 22

Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests 23

Horizon Diagnostics Enters Into Distribution Agreement With Riken Genesis 24

Crown Bioscience Enters Into Agreement With Horizon Discovery To Develop In Vivo Models For Drug Discovery 25

Horizon Diagnostics Enters Into Distribution Agreement With Diatech Pharmacogenetics For Molecular Reference Standards 26

Crown Bioscience Enters Into Co-Development Agreement With Horizon Discovery 27

Horizon Discovery Enters into Licensing Agreement with US Immuno-Oncology Company 28

Horizon Discovery Raises USD104.6 million in Private Placement of Shares 29

Horizon Discovery Group Plc, Key Competitors 30

Horizon Discovery Group Plc, Key Employees 31

Horizon Discovery Group Plc, Other Locations 32

Horizon Discovery Group Plc, Subsidiaries 32

Horizon Discovery Group Plc, Joint Venture 33

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Horizon Discovery Group Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.